Match Day 2026: How Harvard Medical School Students Chose Their Specialty Awaiting residency placements, graduates share excitement about chosen fields. New sensor sniffs out pneumonia on a patient’s breath The technology could enable fast, point-of-care diagnoses for pneumonia and other lung conditions. MIT-Royalty Pharma Faculty Founder Initiative supports biotech innovators Offering substantial prize funding alongside workshops, classes, and mentorship, the initiative helps translate early-stage biotech research into venture-ready innovation. Injectable “satellite livers” could offer an alternative to liver transplantation The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure. Using synthetic biology and AI to address global antimicrobial resistance threat Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed. Pagination First page « First Previous page Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 … Next page Next Last page Last »
Match Day 2026: How Harvard Medical School Students Chose Their Specialty Awaiting residency placements, graduates share excitement about chosen fields.
New sensor sniffs out pneumonia on a patient’s breath The technology could enable fast, point-of-care diagnoses for pneumonia and other lung conditions.
MIT-Royalty Pharma Faculty Founder Initiative supports biotech innovators Offering substantial prize funding alongside workshops, classes, and mentorship, the initiative helps translate early-stage biotech research into venture-ready innovation.
Injectable “satellite livers” could offer an alternative to liver transplantation The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure.
Using synthetic biology and AI to address global antimicrobial resistance threat Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
